TXG 10x Genomics Inc Total Business Assets

Corporate emblem and logo of 10x (TXG)

The linear price action on the 10x Genomics, Inc. (TXG) total assets chart on the GURU.Markets platform, reaching 1005.62, illustrates the growth of the genetic testing developer. Dominance in spatial biology is supported by a vast array of installed equipment. The business relies on patent protection in cell analysis to deter competitors. A strategy of selling consumables to the existing installed base of instruments guarantees revenue stability.

10x (TXG) Company Total Assets: for the period 07/04/2022 - 10/30/2026

Comprehensive metric breakdowns and analytics for 10x Genomics Corp (TXG)

- stock quotes and analyst forecast:
Share Price 10xgenomics.com|TXG - Price Target Chart
- market capitalization data:
Market Capitalization 10x|TXG - Enterprise Value
- book capitalization information:
Book Value per Share 10x Genomics|TXG - Book Capitalization|Market Cap to Book Value Multiple 10xgenomics.com|TXG - Cumulative Company Assets
- debt burden and liquidity indicators:
Debt to Equity Ratio 10x Genomics, Inc.|TXG - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital 10x|TXG - Company Aggregate Debts|Debt to Net Assets 10x|TXG - Company Long-Term Debts|Short-Term Debt 10x Genomics|Immediate Liquidity Ratio 10xgenomics.com
- earnings and market multiples details:
TXG - Company Net Income
Fundamental valuation:TXG (10xgenomics.com)
Brand item of 10x

10x Genomics, Inc. (TXG) leadership in spatial biology and the launch of the Xenium platform require significant capital expenditures in infrastructure and intellectual property. Monitoring total balance sheet assets, calculated reversely via ROA, allows for tracking the efficiency of resource utilization and warns of the risk of declining profitability should the balance sheet become unjustifiably inflated, which is critical for assessing the company's real cost of capital.

Direct competitors

Total Business Assets TEM|Aggregate Company Assets Qiagen|Total Business Assets IONS (Ionis Pharmaceuticals, Inc.)|Company Total Assets RGEN|Company Total Assets Avidity Corp (RNA)|Company Total Assets CRSP (CRISPR Therapeutics AG)|Aggregate Business Assets WGS (genedx.com)|RARE: Cumulative Company Assets|BEAM (Beam Therapeutics Inc) - Total Business Assets|SRPT (Sarepta Therapeutics Inc) - Cumulative Company Assets|Twist Bioscience Corp - Aggregate Asset Value|NTLA (Intellia Therapeutics) - Company Total Assets|STOK - Company Balance Sheet Assets|Company Total Assets BLFS|WVE - Company Assets|Aggregate Company Assets Maze Tx MAZE|SION: Total Business Assets|PRME - Aggregate Company Assets|Company Assets tayshagtx.com|uniQure (QURE) - Aggregate Company Assets|Cumulative Company Assets MeiraGTx Holdings|RGNX (Regenxbio) - Company Total Assets|Solid Corp (SLDB) - Company Total Asset Base|Company Total Assets OCGN|Cumulative Company Assets pacb.com PACB|Aggregate Company Assets Benitec Biopharma BNTC|Company Total Asset Base Design Therapeutics Inc (DSGN)|RCKT: Cumulative Company Assets|Aggregate Asset Value FDMT (4D Molecular Corp)|LXEO: Company Total Assets|KRRO - Company Total Asset Base|Aggregate Company Assets Editas Medicine|Total Business Assets SLN (Silence Therapeutics PLC)|Company Total Assets PRQR|Cumulative Company Assets codexis.com CDXS|Sangamo Therapeutics - Cumulative Company Assets|Company Total Asset Base Nautilus Biotechnology, Inc. (NAUT)|MGX: Cumulative Company Assets|precisionbiosciences.com - Aggregate Business Assets|GBIO (generationbio.com) - Cumulative Company Assets|Total Business Assets BOLD|XCUR (Exicure Inc.) - Company Total Assets|IMNN - Company Balance Sheet Assets|Company Total Assets PHIO|mustangbio.com - Total Business Assets|Aggregate Company Assets TransCode Therapeutics, Inc. RNAZ|BNGO: Total Business Assets|Applied DNA Sciences - Company Total Assets|BLUE - Company Total Assets|IPA: Company Total Assets|OMGA: Aggregate Business Assets|Cumulative Company Assets OMIC|Total Business Assets RGLS (Regulus)|Cumulative Company Assets SYRS (Syros Pharmaceuticals)|TBIO (telesisbio.com) - Aggregate Asset Value|Company Total Assets TCON (TRACON Pharmaceuticals, Inc.)|Company Balance Sheet Assets Unity Biotechnology Inc.